Literature DB >> 7927938

Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence.

D W Visscher1, M Höyhtyä, S K Ottosen, C M Liang, F H Sarkar, J D Crissman, R Fridman.   

Abstract

The 72-kDa (MMP-2, gelatinase A) and the 92-kDa (MMP-9, gelatinase B) matrix metalloproteinases have been associated with tumor cell invasion and metastasis. Immunohistological staining of MMP-2 and MMP-9, basal lamina collagen IV and TIMP-2 were performed on frozen sections of 83 invasive breast carcinomas. MMP-2 and MMP-9 were associated with neoplastic cell plasma membrane in 72% of cases and exhibited inter-tumoral variability of staining intensity. MMP-2 and MMP-9 staining was not correlated with presence of metastases at time of diagnosis or with disease outcome. TIMP-2 was detected in the peri-tumoral stroma and was present in 87% of cases. Residual benign breast tissue was negative for TIMP-2 staining. Neoplasms with diffuse TIMP-2 staining (24%) recurred significantly more frequently (75% recurred) than cases with focal (42% recurred) or absent (27% recurred) TIMP-2. Presence of collagen IV was negatively correlated with gelatinase staining. We conclude that up-regulation of MMP-2 and MMP-9 expression in breast tumor cells is reciprocally correlated to collagen IV staining. Clinical outcome, however, is more closely related to the presence of TIMP-2 than the corresponding MMPs. Enhanced TIMP-2 expression, therefore, may denote a stromal response to tumor invasion, indicative of aggressive behavior in a subset of breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927938     DOI: 10.1002/ijc.2910590308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

Authors:  Y Friedmann; I Vlodavsky; H Aingorn; A Aviv; T Peretz; I Pecker; O Pappo
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

Authors:  E Levi; R Fridman; H Q Miao; Y S Ma; A Yayon; I Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.

Authors:  M M Pacheco; M Mourão; E B Mantovani; I N Nishimoto; M M Brentani
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

Review 5.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

7.  Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.

Authors:  Shohei Koyama
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.

Authors:  C K Lindsay; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

9.  Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

Authors:  Susan MacLauchlan; Eleni A Skokos; Norman Meznarich; Dana H Zhu; Sana Raoof; J Michael Shipley; Robert M Senior; Paul Bornstein; Themis R Kyriakides
Journal:  J Leukoc Biol       Date:  2009-01-13       Impact factor: 4.962

10.  Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

Authors:  S Samantaray; R Sharma; T K Chattopadhyaya; S Datta Gupta; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-16       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.